Managing Symptoms: Treatment and Care Options

Because there is currently no cure or disease-modifying treatment for Pantothenate Kinase-Associated Neurodegeneration (PKAN), the focus of medical care is on managing symptoms and improving quality of life ^[1][2]. The most significant physical challenge in PKAN is dystonia—involuntary muscle contractions that cause twisting and repetitive movements. Your care team will use a combination of medications, therapies, and sometimes surgery to help manage these symptoms.

Medical Management of Dystonia

There is no single “best” drug for PKAN; doctors typically tailor treatment based on which symptoms are most bothersome.

• Oral Medications: Doctors often start with medications like baclofen (a muscle relaxant) or trihexyphenidyl (an anticholinergic) to help loosen stiff muscles ^[3][2]. Other drugs, such as gabapentin or pregabalin, may be used to help with nerve-related pain or discomfort ^[1]. Safety Note: Anticholinergics can cause dry mouth, confusion, or constipation. Never abruptly stop taking baclofen without urgent medical advice.
• Botulinum Toxin (Botox): For dystonia that is limited to specific muscle groups—such as the calves or the jaw—injections of botulinum toxin can temporarily weaken the overactive muscle. This can improve gait, reduce pain, and make daily care easier ^[4][5]. Safety Note: Injections in the jaw or neck can sometimes temporarily worsen chewing or swallowing; discuss injection-specific risks.
• Intrathecal Baclofen: If oral medications are not enough, a surgeon may place a small pump (a baclofen pump) that delivers the medication directly into the fluid surrounding the spinal cord. This can provide stronger relief for severe leg stiffness with fewer systemic side effects than oral doses ^[2]. However, this carries serious risks, including pump infection, catheter failure, overdose, and life-threatening withdrawal if medication delivery is abruptly stopped or the pump runs empty.

Deep Brain Stimulation (DBS)

For individuals whose dystonia does not respond to medication, Deep Brain Stimulation (DBS) is a primary specialized surgical option. This involves placing thin wires into a part of the brain called the globus pallidus internus (GPi). These wires are connected to a battery-powered device, similar to a pacemaker, that sends electrical pulses to regulate abnormal brain signals ^[6][7].

• Expected Benefits: The response to DBS is highly individual. Group averages from small observational studies suggest an overall 26% improvement in motor symptoms at one year ^[6]. The benefit may depend heavily on the subtype:
  • Atypical PKAN: Patients often see a 45% improvement in movement and a reduction in disability on rating scales ^[6].
  • Classic PKAN: Patients typically see less improvement (about 16%) and may not experience a significant change in their overall level of disability ^[6].
• Long-Term Realities: While DBS can provide years of relief from dystonia, it does not stop the underlying disease ^[8]. Over time, symptoms like difficulty swallowing, balance issues, and speech problems may still worsen because they are caused by different parts of the brain that DBS does not target ^[8][9].
• Risks: Like any brain surgery, DBS carries major risks, including bleeding, seizures, surgical infection (seen in about 6% of cases), hardware failure (seen in about 7%), stimulation side effects, repeat operations, and future battery replacement surgeries ^[6].

Rehabilitative and Supportive Care

Non-medical therapies are just as important as drugs or surgery.

• Physical and Occupational Therapy: Daily passive stretching and range-of-motion exercises, as directed by a professional, are vital to prevent contractures (muscles that become permanently shortened and stiff). Never force a painful range of motion. ^[3][10].
• Speech and Swallowing Therapy: Because swallowing difficulties (dysphagia) are a major risk for lung infections (aspiration), regular evaluations by a speech therapist are essential ^[11][8].

Investigational Treatments

While not yet standard care, researchers are actively studying new ways to treat PKAN. Drugs like deferiprone (an iron chelator intended to remove iron from the brain) and fosmetpantotenate (designed to bypass the blocked chemical pathway) have been tested in clinical trials ^[11][12].

• These are investigational treatments, not established routine care.
• Results have been mixed, negative, or inconclusive.
• Iron chelation carries severe risks, such as dangerous drops in white blood cells (agranulocytosis), and should only be used under strict specialist or trial monitoring.

You may wish to ask your doctor about current natural history studies or registries, such as the TIRCON registry, which help researchers understand the disease and prepare for future clinical trials [NCT05522374].